期刊文献+

双吡啶酮缩氨基硒脲的合成工艺改进

Improved synthesis of dipyridyl thioselenosemicarbazones
下载PDF
导出
摘要 目的改进双(2-吡啶)酮缩-4-烯丙基-3-氨基硒脲(4)和双(2-吡啶)酮缩-4,4-二甲基-3-氨基硒脲(8)的合成工艺。方法以4-烯丙基-3-氨基硫脲为起始原料,经碘甲烷甲基化,硒氢化钠取代,最后与双(2-吡啶)酮脱水缩合制得终产物4;以4,4-二甲基-3-氨基硫脲为起始原料,与双(2-吡啶)酮脱水缩合,再经碘甲烷甲基化,硒氢化钠取代,最终制得终产物8;并优化各步反应条件。结果按照相应的合成路线有效制备了目标化合物4和8,目标化合物与中间体的结构均经1H NMR、MS谱确认。结论优化后的工艺路线具有成本低、操作简便、适合大量制备等优点。 Objective To improve the synthesis process of N-allyl-2-(di(pyridin-2-yl)methylene)hydrazinecarboselenoamide(4)and 2-(di(pyridin-2-yl)methylene)-N,N-dimethylhydrazinecarboselenoamide(8). Methods 4-allyl-3-thiosemicarbazide(1)was the starting material,which reacted with methyl iodide,sodium hydrogen selenide to obtain intermediate 4-allyl-3-selenosemicarbazide(3). Compound(3)reacted with di-2-pyridyl ketone to obtain the target compound 4. 4,4-Dimethyl-3-thiosemicarbazide was the starting materials,which reacted with di-2-pyridyl ketone to obtain intermediate dipyridyl thiosemicarbazone(6). Compound 6 reacted with methyl iodide,sodium hydrogen selenide to obtain the target compound 8. We optimized the reaction conditions of each step.Results We synthesized the target compound 4 and 8 according to the respective synthetic route,the structure of the target compounds and the intermediates were confirmed by1 H NMR and MS. Conclusion The improved processes are easy to operate,cost-saving and suitable for large scale preparation.
作者 邢晓东 钟武
出处 《国际药学研究杂志》 CAS CSCD 北大核心 2016年第3期481-484,共4页 Journal of International Pharmaceutical Research
基金 国家自然科学基金面上项目资助(81473139)
关键词 双吡啶酮缩氨基硒脲 金属螯合剂 合成 工艺改进 dipyridyl thioselenosemicarbazones metal-chelator synthesis process improvement
  • 相关文献

参考文献10

  • 1Samuni AM, Krishna MC, Degraff W, et al. Mechanisms underlying the cytotoxic effects of Tachpyr-a novel metal chelator [J]. Biochim Biophys Acta, 2002,1571(3):211-218.
  • 2Yu Y, Gutierrez E, Kovacevic Z, et al. Iron chelators for the treatment of cancer [J]. Curr Med Chem, 2012,19(17):2689-2702.
  • 3Yu Y, Kovacevic Z, Richardson DR. Tuning cell cycle regulation with an iron key [J]. Cell Cycle, 2007,6(16):1982-1994.
  • 4Hancock CN, Stockwin LH, Han B, et al. A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo [J]. Free Radic Biol Med, 2011,50(1):110-121.
  • 5Kalinowski DS, Richardson DR. The evolution of iron chelators for the treatment of iron overload disease and cancer [J]. Pharmacol Rev, 2005,57(4):547-583.
  • 6Yu Y, Wong J, Lovejoy DB, et al. Chelators at the cancer coalface: desferrioxamine to triapine and beyond [J]. Clin Cancer Res, 2006,12(23):6876-6883.
  • 7Tisato F, Marzano C, Porchia M, et al. Copper in diseases and treatments, and copper-based anticancer strategies [J]. Med Res Rev, 2010,30(4):708-749.
  • 8Wang F, Jiao P, Qi M, et al. Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry [J]. Curr Med Chem, 2010,17(25):2685-2698.
  • 9Zhong W, Zhu H, Sheng F, et al. Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cells [J]. Autophagy, 2014,10(7):1285-1300.
  • 10Shen H, Zhu H, Song M, et al. A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells [J]. BMC Cancer, 2014,14:629.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部